Strippoli, Antonia
 Distribuzione geografica
Continente #
NA - Nord America 2.216
AS - Asia 1.550
EU - Europa 1.506
SA - Sud America 291
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 43
OC - Oceania 1
Totale 5.699
Nazione #
US - Stati Uniti d'America 2.135
SG - Singapore 673
DE - Germania 387
IT - Italia 325
CN - Cina 319
SE - Svezia 268
BR - Brasile 225
VN - Vietnam 179
IN - India 112
FR - Francia 108
GB - Regno Unito 72
FI - Finlandia 55
IE - Irlanda 52
CA - Canada 41
PL - Polonia 40
JP - Giappone 39
ID - Indonesia 38
HK - Hong Kong 36
UA - Ucraina 35
BD - Bangladesh 33
RU - Federazione Russa 33
TR - Turchia 32
AR - Argentina 26
NL - Olanda 26
MX - Messico 22
BE - Belgio 19
IQ - Iraq 18
AT - Austria 14
EC - Ecuador 14
ES - Italia 14
IR - Iran 14
CI - Costa d'Avorio 13
ZA - Sudafrica 12
CZ - Repubblica Ceca 11
KR - Corea 10
LT - Lituania 10
SA - Arabia Saudita 9
CH - Svizzera 8
PE - Perù 7
JO - Giordania 6
PK - Pakistan 6
CO - Colombia 5
RO - Romania 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
IL - Israele 4
JM - Giamaica 4
MA - Marocco 4
EG - Egitto 3
GE - Georgia 3
HU - Ungheria 3
PT - Portogallo 3
TN - Tunisia 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
HN - Honduras 2
KE - Kenya 2
LK - Sri Lanka 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PY - Paraguay 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
UY - Uruguay 1
Totale 5.609
Città #
Singapore 405
Ashburn 242
Chandler 234
San Jose 180
New York 92
Beijing 70
Los Angeles 63
The Dalles 60
Chicago 57
Rome 53
Ho Chi Minh City 52
Hanoi 51
Dublin 49
Cattolica 48
Ann Arbor 46
San Mateo 39
Milan 38
Tokyo 38
Warsaw 37
Wilmington 37
Lauterbourg 35
Hyderabad 34
Jakarta 32
Hong Kong 30
Council Bluffs 29
Fairfield 29
Hefei 28
Helsinki 28
Houston 27
Santa Clara 27
Munich 25
Jacksonville 24
Nanjing 24
Boston 23
Dearborn 22
São Paulo 22
Frankfurt am Main 21
Moscow 21
Boardman 20
Woodbridge 20
Brussels 18
Nürnberg 18
Seattle 18
Orem 17
Shanghai 17
Marseille 16
Dallas 15
Denver 15
Falls Church 15
Princeton 15
Redwood City 15
St Louis 15
Chennai 14
Abidjan 13
Brooklyn 13
Redmond 13
Augusta 12
Manchester 12
Montreal 12
Toronto 12
Buffalo 10
Phoenix 10
Brno 9
Cambridge 9
Hangzhou 9
Izmir 9
Johannesburg 9
Kent 9
Lappeenranta 9
Lawrence 9
Nanchang 9
Amsterdam 8
Da Nang 8
Guayaquil 8
Istanbul 8
London 8
Mexico City 8
Nuremberg 8
Seoul 8
Turku 8
Ankara 7
Baghdad 7
Bari 7
Newark 7
Poplar 7
Stockholm 7
Zurich 7
Amman 6
Atlanta 6
Bologna 6
Campinas 6
Curitiba 6
Düsseldorf 6
Jeddah 6
Kish 6
Mountain View 6
Mumbai 6
Paris 6
Rio de Janeiro 6
San Francisco 6
Totale 3.007
Nome #
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 329
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 307
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 236
Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment 235
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 228
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 214
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 198
Enhanced recovery after surgery (ERAS) versus standard recovery for gastric cancer patients: The evidences and the issues: ERAS and Gastric Cancer 164
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 162
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 162
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 160
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 156
The Role of Surgery in the Management of Gastric Cancer: State of the Art 153
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 148
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas 147
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 146
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 143
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 142
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 140
The Role of Staging Laparoscopy for Gastric Cancer Patients: Current Evidence and Future Perspectives 139
Preoperative therapy and long-term survival in gastric cancer: One size does not fit all 138
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer 136
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 135
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study) 130
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 130
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 130
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 129
Surgery for locally advanced gastric cancer in the era of neoadjuvant therapies: something new? 126
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 126
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 121
Gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatments 112
Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis 106
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 105
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis 99
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 92
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer 88
The interference between oxaliplatin & anti-EGFR therapies: A different hypothesis to explain the 'unexplainable' 87
Totale 5.699
Categoria #
all - tutte 21.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022380 0 18 14 71 16 15 8 55 17 27 55 84
2022/2023670 102 86 37 109 28 80 39 49 41 26 22 51
2023/2024424 18 80 12 11 10 68 38 23 21 20 33 90
2024/2025828 22 29 69 25 72 32 39 33 98 105 169 135
2025/20262.319 267 67 137 350 434 127 379 135 143 135 100 45
2026/2027142 65 77 0 0 0 0 0 0 0 0 0 0
Totale 5.699